Malin may issue €30m in shares

Company plans to sell between 2.5 million and 3 million shares in the company at €10 each

30th April, 2017
John Given

Malin, the biotech investment fund backed by former executives of drug firm Elan, is considering issuing up to €30 million in new shares.

The company told the Irish stock exchange last Friday that in response to market demand it plans to sell between 2.5 million and 3 million shares in the company at €10 each.

Dublin-based Malin is backed by a number of high-profile investors, including the state owned Irish Strategic Investment Fund, Aviva and Kelly Martin...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Tom Maguire: Tax changes we make now could help business for years

More Business Tom Maguire 9 months ago

The Daily Briefing

The Daily Briefing